His research interests focus on anti-infective pharmacokinetics, pharmacodynamics, and efficacy in both pediatric and adult patients. Dr. Bosso has published articles in Pharmacotherapy, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, The Pediatric Infectious Disease Journal, Diagnostic Microbiology and Infectious Disease, Clinical Infectious Diseases, and The Journal of Infectious Diseases Pharmacotherapy. He has written chapters for textbooks that include Pharmacotherapy: A Pathophysiologic Approach, The Pharmacotherapy Self-Assessment Program, and The Textbook of Pediatric Infectious Diseases. He is a member of the editorial boards of Antimicrobial Agents and Chemotherapy, Pharmacotherapy, and The Journal of Pediatric Pharmacology and Therapeutics.
Dr. Bosso has been active in a number of professional organizations, and was a founding member and a past-president of the Society of Infectious Diseases Pharmacists, and a past-president of the American College of Clinical Pharmacy.
Debra A. Goff, PharmD, FCCP
Infectious Disease Specialist
Clinical Associate Professor
The Ohio State University Medical Center, Columbus, OH
She is a member of the OSUMC Antimicrobial Stewardship Program, and is actively involved in developing strategies to control the escalating rate of antimicrobial resistance. The team manages both community-acquired and healthcare-associated infections. She recently developed a medical “app” called STAB-IT (Staph aureus bacteremia – is terrible) to help educate clinicians at OSUMC on the management of patients with Staph aureus bacteremia. Dr. Goff is the first medical educator to conduct a workshop on “Medical apps for Healthcare Professionals: Using the iPad to Educate”, at the Apple® store in Columbus, OH.
She has received numerous research grants and has lectured both nationally and internationally. Dr. Goff has published in several journals, including Clinical Infectious Diseases, Archives of Internal Medicine, Pharmacotherapy, Current Opinion in Infectious Diseases, and Journal of Infection.
Dr. Goff is an active member of Infectious Diseases Society of America, American College of Clinical Pharmacy, American Society for Microbiology, Society of Infectious Disease Pharmacists, and a board member of the National Foundation for Infectious Diseases. When she is not working, Dr. Goff can be found doing triathlons and photography.
Keith S. Kaye, MD, MPH, FIDSA, FSHEA, FACP
Professor of Medicine
Corporate Medical Director, Hospital Epidemiology and Antimicrobial Stewardship
Detroit Medical Center and Wayne State University, Detroit, MI
Dr. Kaye’s particular clinical interests and skills are infections in the elderly, intravascular catheter-related infections, epidemiology of and outcomes associated with multidrug resistant bacteria, risk adjustment, prevention, risk factors and outcomes related to surgical site infections and infected prosthetic devices, antimicrobial resistance and infection control issues in community hospitals and tertiary care hospitals, and antimicrobial stewardship.
His principle research areas of interest include hospital-acquired infections, hospital epidemiology, infections in the elderly, antimicrobial resistance, surgical site infection, bloodstream infection, and antibiotic utilization. He is currently studying hospital-acquired infections in the elderly with partial funding for a career development grant from the National Institutes of Health.
Dr. Kaye has authored over 60 peer-reviewed articles and 5 book chapters and has presented numerous abstracts at national conferences.
Jason Newland, MD, MS
Director, Antimicrobial Stewardship Program and
Director, Evidence-based Practice
Children’s Mercy Hospital, Kansas City, MO
Dr. Newland grew up in southwest Oklahoma, and obtained his B.S. in Pre-professional studies at the University of Notre Dame in 1996 and medical degree from the University of Oklahoma College of Medicine in 2000. He completed pediatric residency at the University of Nebraska/Creighton Medical Centers in 2003 and fellowship in Pediatric infectious diseases at the Children’s Hospital of Philadelphia in 2006, distinguishing himself with teaching awards at both the resident and fellow level.
In August of 2006, he joined the faculty at Children’s Mercy Hospitals & Clinics in Kansas City, Missouri where he is the director of the antimicrobial stewardship program and the director of evidence-based practice. An active resident and faculty mentor, he recently completed his master’s in education through a joint program offered by the Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Education, focusing on adult learning, curriculum and teaching methods, and medical education evaluation and research.
His current research spotlights the use of antimicrobials and the impact of an antimicrobial stewardship program at a children’s hospital. Additionally, he is interested in the impact of clinical practice guidelines on the care of children. Finally, he has developed mobile apps to further enhance the delivery of guidelines to the practicing clinician.
Joseph A. Paladino, PharmD, FCCP
Director, Outcomes Research
CPL Associates, LLC
Clinical Professor
University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY
Dr. Paladino completed a Bachelor of Science degree in biology from Siena College in Albany, New York, earned his pharmacy degree from the Massachusetts College of Boston, and received a Doctor of Pharmacy degree from the Medical University of South Carolina. His research interests include clinical trials of antimicrobial agents, and outcomes analysis, specifically, pharmacoeconomics and pharmacoepidemiology.
He is Consulting Editor of PharmacoEconomics, a member of the editorial board of Surgical Infections, and a reviewer for many journals, including Clinical Infectious Diseases, Archives of Internal Medicine, Pharmacotherapy, Journal of Antimicrobial Chemotherapy, Drugs, Antimicrobial Agents and Chemotherapy, Journal of Infectious Diseases, and theAmerican Journal of Health-Systems Pharmacy.
Dr. Paladino has authored more than 100 publications in peer-reviewed journals and several book chapters. His professional memberships include Infectious Diseases Society of America, American Society for Microbiology, Society of Infectious Diseases Pharmacists, American College of Clinical Pharmacy, and International Society for Pharmacoeconomics and Outcomes Research.
Dr. Paladino has lectured in 30 countries, trained eleven post-doctoral fellows, and has served as a sabbatical host for pharmacy and medical practitioners, fellows, and students from Germany, Scotland, and Russia. He has received numerous scholarships and awards, including being named a Fellow of the American College of Clinical Pharmacy, the 1998 Excellence in Research Award of the International Society for Pharmacoeconomics and Outcomes Research, and inclusion in Who’s Who in the World.
Michael J. Rybak, PharmD, MPH, FCCP
Associate Dean for Research
Professor of Pharmacy and Medicine
Director, Anti-Infective Research Laboratory
Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI
Dr. Rybak is Associate Dean for Research and Professor of Pharmacy at the Eugene Applebaum College of Pharmacy and Health Sciences (EACPHS). He is also an Adjunct Professor of Medicine in the Division of Infectious Diseases at the School of Medicine at Wayne State University in Detroit, Michigan. Dr. Rybak is Director of the Anti-Infective Research Laboratory at EACPHS, and is affiliated with Detroit Receiving Hospital and University Health Center.
He received his undergraduate degree in Pharmacy from Northeastern University in Boston, Massachusetts, his PharmD from the College of Pharmacy and Health Sciences, and his MPH from the School of Medicine at Wayne State University.
Dr. Rybak’s primary research focus is antimicrobial pharmacokinetics and pharmacodynamics (PK/PD) and their relationship to bacterial resistance. He has published several book chapters and numerous articles in scientific journals on topics such as antimicrobial PK/PD and resistance to antimicrobial agents, the importance of bactericidal drugs, and the assessment of patient outcome as it relates to antimicrobial resistance issues. Dr. Rybak is the Scientific Field Editor for the Infectious Diseases section of Pharmacotherapy, and serves as an editorial reviewer for a number of other scientific publications.
He is a member of several professional societies, including the American College of Clinical Pharmacy, the American Society of Health-System Pharmacists, the Society of Infectious Diseases Pharmacists, the American Society for Microbiology, and the Infectious Diseases Society of America.
Jack D. Sobel, MD, FIDSA
Professor of Medicine
Chief, Division of Infectious Diseases
Department of Internal Medicine
Wayne State University School of Medicine
Detroit Medical Center, Detroit, MI
Dr. Sobel received his medical degree from the University of Witwatersrand in Johannesburg, South Africa. He completed his residency in internal medicine in Johannesburg, and Haifa, Israel, and a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases/National Institutes of Health, in Bethesda, Maryland, and the Medical College of Pennsylvania in Philadelphia.
Dr. Sobel considers himself a candidologist rather than a general mycologist. His primary clinical interests relate to invasive candidiasis and candidemia and superficial infections caused by Candida. He has written extensively and performed research for many years in the field of vulvovaginal candidiasis. Dr. Sobel also has an interest in urinary candidiasis and continues to focus his clinical and laboratory research in both these forms of superficial candidiasis.
His research laboratory is involved in studies related to pathogenesis of vulvovaginal candidiasis, with a current focus on the use of polymerase chain reaction (PCR) diagnosis and molecular methodologies to research the natural history of vulvovaginal candidiasis.
Dr. Sobel directs the Wayne State University vulvovaginitis clinic, where he is actively involved in studying all forms of infectious vaginitis, and has developed a variety of new agents for diagnosis of vaginitis and strategies for managing refractory vaginitis due to Candida and bacterial etiologies. For several years, Dr. Sobel has served as a leader for the MSG Candida section in the development of clinical trials for evaluating new drugs to prevent and treat invasive candidiasis.